Corrections: Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study (The Lancet Infectious Diseases (2018) 18(1) (76–84)(S1473309917306916)(10.1016/S1473-3099(17)30691-6));Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study

The Lancet Infectious Diseases

Volumn 18, Issue 1, 2018, Pages 76-84

  Dorman, Susan E ^a,q   Schumacher, Samuel G ^b,q   Alland, David ^c,q   Nabeta, Pamela ^b,q   Armstrong, Derek T ^a,q   King, Bonnie ^a,q   Hall, Sandra L ^d,q   Chakravorty, Soumitesh ^c,q   Cirillo, Daniela M ^e   Tukvadze, Nestani ^f,q   Bablishvili, Nino ^f,q   Stevens, Wendy ^g,q   Scott, Lesley ^g   Rodrigues, Camilla ^h,q   Kazi, Mubin I ^h,q   Joloba, Moses ^i,q   Nakiyingi, Lydia ^i,q   Nicol, Mark P ^j,k,q   Ghebrekristos, Yonas ^j,k,q   Anyango, Irene ^l,q   Murithi, Wilfred ^l,q   Dietze, Reynaldo ^m,q   Lyrio Peres, Renata ^m   Skrahina, Alena ^n,q   Auchynka, Vera ^n,q   Chopra, Kamal Kishore ^o,q   Hanif, Mahmud ^o,q   Liu, Xin ^p,q   Yuan, Xing ^p,q   Boehme, Catharina C ^b,q   Ellner, Jerrold J ^d,q   Denkinger, Claudia M ^b,q   Peres, Renata Lyrio ^q   Manabe, Yukari C ^q   Hom, David ^q   Aspindzelashvili, Rusudan ^q   David, Anura ^q   Surve, Utkarsha ^q   Kamulegeya, Louis Henry ^q   Nabweyambo, Sheila ^q   Surtie, Shireen ^q   Hapeela, Nchimunya ^q   Cain, Kevin P ^q   Agaya, Janet ^q   McCarthy, Kimberly D ^q   Marques Rodrigues, Patricia ^q   Schmidt Castellani, Luiz Guilherme ^q   Almeida, Pedro Sousa ^q   de Aguiar, Paola Poloni Lobo ^q   Solodovnikova, Varvara ^q   Ruan, Xianglin ^q   Liang, Lili ^q   Zhang, Guolong ^q   Zhu, Hong ^q   Xie, Yingda ^q   more..

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FIND   (Switzerland)

^c RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e SAN RAFFAELE HOSPITAL   (Italy)

^f National Centre for Tuberculosis and Lung Disease   (Georgia)

^g NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

^h P D HINDUJA NATIONAL HOSPITAL   (India)

ⁱ MAKERERE UNIVERSITY   (Uganda)

^j UNIVERSITY OF CAPE TOWN   (South Africa)

^k UNIVERSITY OF CAPE TOWN   (South Africa)

^l KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^m FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

ⁿ Republican Scientific and Practical Centre for Pulmonology and Tuberculosis   (Belarus)

^o New Delhi TB Centre   (India)

^p Department of Cardiology   (China)

^q NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLOW UP; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SPUTUM ANALYSIS; SPUTUM CULTURE; AFRICA; ASIA; BRAZIL; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG EFFECT; EUROPE; EVALUATION STUDY; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; MOLECULAR DIAGNOSIS; MULTIDRUG RESISTANT TUBERCULOSIS; PROCEDURES; SPUTUM;

ADULT; AFRICA; ANTIBIOTICS, ANTITUBERCULAR; ASIA; BACTERIOLOGICAL TECHNIQUES; BRAZIL; DRUG RESISTANCE, BACTERIAL; EUROPE; FEMALE; HUMANS; MALE; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; MYCOBACTERIUM TUBERCULOSIS; PROSPECTIVE STUDIES; RIFAMPIN; SENSITIVITY AND SPECIFICITY; SPUTUM; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 85035313153     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(18)30169-5     Document Type: Erratum

References (24)

1. WHO. Global tuberculosis report 2016. 2016, World Health Organization, Geneva.
2. Uplekar, M, Weil, D, Lonnroth, K, et al. WHO's new end TB strategy. Lancet 385 (2015), 1799–1801.
3. Boehme, CC, Nabeta, P, Hillemann, D, et al. Rapid molecular detection of tuberculosis and rifampicin resistance. N Engl J Med 363 (2010), 1005–1015.
4. Steingart, KR, Schiller, I, Horne, DJ, Pai, MP, Boehme, CC, Dendukuri, N, Xpert MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev, 1, 2014 CD009593.
5. WHO. Xpert MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and children: policy update. 2013, World Health Organization, Geneva.
6. WHO. WHO monitoring of Xpert MTB/RIF roll-out. 2014, World Health Organization, Geneva.
7. Nicol, MP, Workman, L, Isaacs, W, et al. Accuracy of the Xpert MTB/RIF test for the diagnosis of pulmonary tuberculosis in children admitted to hospital in Cape Town, South Africa: a descriptive study. Lancet Infect Dis 11 (2011), 819–824.
8. Theron, G, Peter, J, van Zyl-Smit, R, et al. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting. Am J Respir Crit Care Med 184 (2011), 132–140.
9. Sohn, H, Aero, AD, Menzies, D, et al. Xpert MTB/RIF testing in a low tuberculosis incidence, high-resource setting: limitations in accuracy and clinical impact. Clin Infect Dis 58 (2014), 970–976.
10. Theron, G, Peter, J, Dowdy, D, Langley, I, Squire, SB, Dheda, K, Do high rates of empirical treatment undermine the potential effect of new diagnostic tests for tuberculosis in high-burden settings?. Lancet Infect Dis 14 (2014), 527–532.
11. Theron, G, Zijenah, L, Chanda, D, et al. Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial. Lancet 383 (2014), 424–435.
12. Mathys, V, van de Vyvere, M, de Droogh, E, Soetaert, K, Groenen, G, False-positive rifampicin resistance on Xpert MTB/RIF caused by a silent mutation in the rpoB gene. Int J Tuberc Lung Dis 18 (2014), 1255–1257.
13. Ocheretina, O, Byrt, E, Mabou, MM, et al. False-positive rifampin resistant results with Xpert MTB/RIF version 4 assay in clinical samples with a low bacterial load. Diagn Microbiol Infect Dis 85 (2016), 53–55.
14. Chakravorty, S, Simmons, AM, Rowneki, M, et al. The new Xpert MTB/RIF Ultra: improving detection of Mycobacterium tuberculosis and resistance to rifampin in an assay suitable for point-of-care testing. MBio 8 (2017), e00812–e00817.
15. Global Laboratory Initiative. Mycobacteriology laboratory manual. 2014, Global Laboratory Initiative, Geneva.
16. Rothmann, MD, Wiens, BL, Chan, ISF, Design and analysis of non-inferiority trials. 2014, Chapman & Hall/CRC, Boca Raton, FL.
17. FDA. Guidance for industry. Non-inferiority clinical trials. 2010, Food and Drug Administration, Silver Spring, MD.
18. Cleveland, WS, Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc 74 (1979), 829–836.
19. Zar HJ, Workman L, Nicol MP. Diagnosis of pulmonary tuberculosis in HIV-infected and uninfected children using Xpert MTB/RIF Ultra. International Conference of the American Thoracic Society; Washington, DC, USA; May 19–24, 2017. Abstr A7610.
20. Bahr, NC, Nuwagira, E, Evans, EE, et al. Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in HIV-infected adults: a prospective cohort study. Lancet Infect Dis, 2017 published online Sept 14. http://dx.doi.org/10.1016/S1473-3099(17)30474-7.
21. Theron, G, Venter, R, Calligaro, G, et al. Xpert MTB/RIF results in patients with previous tuberculosis: can we distinguish true from false positive results?. Clin Infect Dis 62 (2016), 995–1001.
22. Malherbe, ST, Shenai, S, Ronacher, K, et al. Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure. Nat Med 22 (2016), 1094–1100.
23. Hofmann-Thiel, S, Hoffmann, H, Evaluation of the Fluortype MTB for detection of Mycobacterium tuberculosis complex DNA in clinical specimens in a low-incidence country. BMC Infect Dis, 14, 2014, 59.
24. Hofmann-Thiel, S, Molodtsov, N, Antonenka, U, Hoffmann, H, Evaluation of the Abbott RealTime MTB and RealTime MTB INH/RIF assays for direct detection of Mycobacterium tuberculosis complex and resistance markers in respiratory and extrapulmonary specimens. J Clin Microbiol 54 (2016), 3022–3027.